Product

Company

NCT00983554·2 sites·ClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

With

Age

24–51

Sex

MALE

Healthy volunteers

Accepted

pituitary tumors
HIV infection
Klinefelter's syndrome
Kallman's syndrome
uncontrolled hypertension
diabetes
congestive heart failure
chronic lung disease
acute coronary syndrome
PSA \>4µg/L
aspartate aminotransferase (AST)\> 3x upper limit of normal
use of medications that might affect weight loss, muscle or bone metabolism or androgen metabolism, action or clearance.
involvement in daily resistance training or high endurance exercise
alcohol or drug dependence
obstructive sleep apnea

The record

StatusUnknown

PhaseNo phase

Taking part57

StartedJun 2005

UpdatedMar 16, 2011

Conditions

Where2

Clareo Health | Metabolic Effects of Steroids in Obese Men